Enteral nutrition with omega-3 polyunsaturated fatty acid in acute respiratory distress syndrome / 中国小儿急救医学

ABSTRACT

Acute respiratory distress syndrome (ARDS) is a common clinical critical disease threatening patient's life,inflammation caused by diffuse alveolar damage is the essence.Omega-3 polyunsaturated fatty acid(ω-3PUFAs) can inhibit inflammation by decreasing arachidonic acid metabolites through competing with arachidonic acid by a variety of ways,by changing the nature of cell membrane signal platform lipid rafts,by involving in inflammation regression and tissue repairment using its metabolites,by reducing the activation of nulear factors-κB and inhibiting the release of inflammatory mediators in local lung tissue.So,ω-3PUFAs has become the research hot spot in ARDS drug treatment.The clinical study on ω-3PUFAs enteral nutrition in the treatment of ARDS has not yet reached the consistent conclusion,therefore,the multicenter randomized controlled trial is needed.